| n (%) or median (range) |
---|---|
Days from operation to administration, day | 54 (31–70) |
Completion rate, % | 25 (54.3%) |
Completion rate without recurrence, % | 25 (62.5%) |
Reson of cessation (n = 21) | |
 Recurrence | 6 (28.6%) |
 Adverse event | 13 (61.9%) |
 Gastrointestinal | 8 |
 Myelosuppression | 2 |
 Stomatitis | 1 |
 Cholangitis | 1 |
 Chest pain | 1 |
 Others | 2 (9.5%) |
 Traffic accident | 1 |
 House-moving | 1 |
 Relative dose intensity, % | 62.9 (0.7–100) |